Cargando…
FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis
Recent studies have reported that FERMT1, a newly discovered adhesion protein, contributes to an aggressive phenotype in several solid malignancies. However, the function and regulatory mechanism of FERMT1 in gastric cancer remain unknown. We found that FERMT1 was overexpressed in gastric cancer tis...
Autores principales: | Fan, Hua, Zhang, Shengjun, Zhang, Yu, liang, Wu, Cao, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515530/ https://www.ncbi.nlm.nih.gov/pubmed/32723205 http://dx.doi.org/10.1080/15384047.2020.1792218 |
Ejemplares similares
-
Alzheimer’s risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/β-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer
por: Xia, Wenzhen, et al.
Publicado: (2022) -
DEC1 promotes progression of Helicobacter pylori‐positive gastric cancer by regulating Akt/NF‐κB pathway
por: Jia, Yanfei, et al.
Publicado: (2022) -
High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2020) -
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF-κB pathway
por: Ye, Jiecheng, et al.
Publicado: (2022) -
AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-κB Pathway
por: Guo, Kai, et al.
Publicado: (2020)